Ovation® Fertility is pleased to announce that Nirvika Singh Sharma, MS, ELD (ABB), MBBS, ELS, ALS, has joined the company as an associate lab director, effective February 7, 2022. In this role, she will oversee IVF, embryology and andrology operations at the Ovation Fertility San Antonio IVF lab, while helping to ensure lab safety and compliance.

Ovation® Fertility is pleased to announce that Aldo Esterhuizen, PhD, HCLD (ABB), has joined the company as a lab director. In this role, she will oversee all IVF, embryology and andrology operations at the Ovation Fertility Nashville IVF lab, while ensuring lab safety and compliance.

Today, researchers at Alife Health, a fertility technology company building artificial intelligence (AI) tools designed to improve in-vitro fertilization (IVF) outcomes, published data on embryo prioritization using AI technology. The study, published online in Fertility and Sterility, was conducted in collaboration with partners at some of the world’s leading fertility clinics, including Shady Grove, Boston IVF, Ovation Fertility, Cornell, IVF Florida, and RSC Bay Area.

IVF services company Ovation Fertility announces the publication of a new collaborative study, “Human embryonic genome activation initiates at the one-cell stage.” The groundbreaking study reveals that genes in human embryos rapidly become active soon after fertilization, at the single-cell stage, rather than at the multicell stage as previously believed. A summary of the research is now available online at OvationFertility.com and at Cell Stem Cell.

Ovation® Fertility is pleased to announce the addition of Judi Beachum to its senior leadership team. As vice president, human resources, Beachum will be responsible for leading Ovation’s human resources operations, bringing valuable expertise in culture definition, recognition, mergers and acquisitions, executive and management development, succession planning, identifying future leaders, recruiting, compensation, benefits, employee relations, and compliance with labor laws.

Ovation^® Fertility’s nationwide team of leading IVF scientists is presenting three oral and 10 poster presentations at the ASRM 2021 Scientific Congress and Expo.

IVF services company Ovation Fertility announces the publication of a new study, “Automated detection of poor-quality data: case studies in healthcare,” by Scientific Reports, a Nature portfolio journal. The study, which focuses on a novel data cleansing technique to improve the use of artificial intelligence in embryo selection in IVF and in pneumonia detection in chest X-rays, is now available online at OvationFertility.com and at Nature.com.